Publication (s)  

International Journal of Infectious Diseases 

Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort studyAl Sulaiman KA, Aljuhani O, Eljaaly K, Alharbi AA, Al Shabasy AM, Alsaeedi AS, Al Mutairi  , Badreldin HA, Al Harbi SA, Al Haji HA, Al Zumai OI, Vishwakarma RK, Alkatheri A. Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study. Int J Infect Dis. 2021 Apr;105:180-187. doi: 10.1016/j.ijid.2021.02.037. Epub 2021 Feb 15. PMID: 33601030; PMCID: PMC7882917.

Annals of Pharmacotherapy

Effect of Acetaminophen on the Prevention of Acute Kidney Injury in Patients With SepsisPatanwala AE, Aljuhani O, Bakhsh H, Erstad BL. Effect of Acetaminophen on the Prevention of Acute Kidney Injury in Patients With Sepsis. Ann Pharmacother. 2018 Jan;52(1):48-53. doi: 10.1177/1060028017728298. Epub 2017 Aug 24. PMID: 28836466.

American Heart Journal Plus: Cardiology Research and Practice 

Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study Saleh KB, Hafiz A, Alsulaiman K, Aljuhani O, Alharbi S, Alharbi A, Vishwakarma R, Albekairy A, Alkathiri A, Alanazi F, Almujarri G, Alobathani S, Alharbi Y, Zowawi HM, Badreldin HA. Clinical characteristics and outcomes of patients with heart failure admitted to the intensive care unit with coronavirus disease 2019 (COVID-19): A multicenter cohort study. Am Heart J Plus. 2021 Jul;7:100033. doi: 10.1016/j.ahjo.2021.100033. Epub 2021 Jul 19. PMID: 34308397; PMCID: PMC8288252.

Pharmacology Research & Perspectives 

Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort studyAl Sulaiman K, Al Aamer K, Al Harthi A, et al. Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study. Pharmacol Res Perspect. 2020;8(4):e00624. doi:10.1002/prp2.624

Annals of Saudi Medicine

Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factorsAlalawi M, Aljahdali S, Alharbi B, Fagih L, Fatani R, Aljuhani O. Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factors. Ann Saudi Med. 2020 Jul-Aug;40(4):305-309. doi: 10.5144/0256-4947.2020.305. Epub 2020 Aug 6. PMID: 32757991; PMCID: PMC7410223.

Critical Care

Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched studyAl Sulaiman K, Aljuhani O, Al Dossari M, Alshahrani A, Alharbi A, Algarni R, Al Jeraisy M, Al Harbi S, Al Katheri A, Al Eidan F, Al Bekairy AM, Al Qahtani N, Al Muqrin M, Vishwakarma R, Al Ghamdi G. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study. Crit Care. 2021 Jun 30;25(1):223. doi: 10.1186/s13054-021-03648-9. PMID: 34193235; PMCID: PMC8242279.

Australian Critical Care

A cross-sectional study of predictors of pain control during the transition from the surgical intensive care unit to surgical wardPatanwala AE, Aljuhani O, Erstad BL. A cross-sectional study of predictors of pain control during the transition from the surgical intensive care unit to surgical ward. Aust Crit Care. 2018 May;31(3):159-164. doi: 10.1016/j.aucc.2018.01.002. Epub 2018 Mar 21. PMID: 29571597.

Saudi Critical Care Journal 

Postintensive Care Unit Follow‑up General Health Survey: A Cross‑Sectional Study in a Tertiary Academic HospitalAljuhan O, Tirkistani A, Albeeshy M, Alnahdi A. Postintensive care unit follow-up general health survey: A cross-sectional study in a tertiary academic hospital. Saudi Crit Care J [serial online] 2021 [cited 2021 Sep 15];5:19-23. Available from: https://www.sccj-sa.org/text.asp?2021/5/2/19/319309

Journal of Critical Care

Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort studyAl Sulaiman K, Aljuhani O, Bin Salah K, Korayem GB, Eljaaly K, Al Essa M, Kharbosh A, Al Harbi F, Abuzaid M, Al Bilal S, Almagthali A, Alsohemi S, Alshabasy A, Noureldeen H, Aboudeif M, Alshehri A, Vishwakarma R. Single versus multiple doses of Tocilizumab in critically ill patients with coronavirus disease 2019 (COVID-19): A two-center, retrospective cohort study. J Crit Care. 2021 Aug 23;66:44-51. doi: 10.1016/j.jcrc.2021.08.007. Epub ahead of print. PMID: 34438133; PMCID: PMC838172

Saudi Critical Care Journal 

Critical Care Pharmacy Services in the Western Region of Saudi ArabiaAljuhani OA. Critical care pharmacy services in the Western Region of Saudi Arabia. Saudi Crit Care J [serial online] 2020 [cited 2021 Sep 15];4:66-72. Available from: https://www.sccj-sa.org/text.asp?2020/4/2/66/288731

Scientific Reports

Ascorbic acid as an adjunctive therapy in critically ill patients with COVID‑19: a propensity score matched studyAl Sulaiman K, Aljuhani O, Saleh KB, Badreldin HA, Al Harthi A, Alenazi M, Alharbi A, Algarni R, Al Harbi S, Alhammad AM, Vishwakarma R, Aldekhyl S. Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study. Sci Rep. 2021 Sep 3;11(1):17648. doi: 10.1038/s41598-021-96703-y. PMID: 34480041; PMCID: PMC8417267.

Expert Review of Anti-infective Therapy

Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case–control studyAleidan FAS, Alkhelaifi H, Alsenaid A, Alromaizan H, Alsalham F, Almutairi A, Alsulaiman K, Abdel Gadir AG. Incidence and risk factors of carbapenem-resistant Enterobacteriaceae infection in intensive care units: a matched case-control study. Expert Rev Anti Infect Ther. 2021 Mar;19(3):393-398. doi: 10.1080/14787210.2020.1822736. Epub 2020 Sep 20. PMID: 32930620.

Therapeutics and Clinical Risk Management

Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and MortalityAlshehri N, Ahmed AE, Yenugadhati N, Javad S, Al Sulaiman K, M Al-Dorzi H, Aljerasiy M, Badri M. Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality. Ther Clin Risk Manag. 2020 Oct 14;16:979-987. doi: 10.2147/TCRM.S266295. PMID: 33116547; PMCID: PMC7569025.

Journal of Clinical Medicine

Efficacy of Empiric Antibiotic Coverage in Community-Acquired Pneumonia Associated with Each Atypical Bacteria: A Meta-AnalysisKhalid Eljaaly, Ahmed Aljabri, Ali A. Rabaan, Ohoud Aljuhani, Abrar K. Thabit, Mohannad Alshibani and Thamer A. Almangour 

Saudi Pharmaceutical Journal

Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacyGhazwa B. Korayem, Hisham A. Badreldin, Khalid Eljaaly, Ahmed Aldemerdash, Lujain K. Al-Suhaibani,, Hala Joharji, Ohoud Aljuhani, Bedor A. Al-Omar, Hajer Y. Almudaiheem, Abdullah A. Alhifany, Mohammad Alawagi, Sahar M. Al-Mowaina, Abdulrazaq S. Al-Jazairi, Abdulkareem M. Albekairy, Ahmed Al-Jedai

Journal of The American College of Clinical Pharmacy

Critical care pharmacy in Saudi Arabia: Historical evolution and future directions—A review by the Critical Care and Emergency Medicine Pharmacy Specialty Network at the Saudi Society of Clinical PharmacyAbdulrahman I. Alshaya Pharm.D., Abdullah M. Alhammad Pharm.D., Nadia Ismail BScPharm, M.Sc., Nada Alkhani Pharm.D., Shmeylan Alharbi Pharm.D., Ahmed O. Alenazi Pharm.D., Ohoud Aljuhani Pharm.D.,

Journal of Family and Community Medicine

Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi ArabiaAlsulaiman TA, Al-Ajmi HA, Al-Qahtani SM, Fadlallah IM, Nawar NE, Shukerallah RE, Nadeem SR, Al-Weheedy NM, Al-Sulaiman KA, Hassan AA, Shahin AA, Kolib TM. Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia. J Family Community Med. 2016 Jan-Apr;23(1):1-5. doi: 10.4103/2230-8229.172221. Erratum in: J Family Community Med. 2016 May-Aug;23(2):122. PMID: 26929722; PMCID: PMC4745195.

American Journal of Therapeutics

Effect of Methocarbamol on Acute Pain After Traumatic InjuryAljuhani, Ohoud PharmD; Kopp, Brian J. PharmD; Patanwala, Asad E. PharmD

BMC Pharmacology and Toxicology

Association between β-blocker use and mortality in critically ill patients: a nested cohort studyAl Harbi SA, Al Sulaiman KA, Tamim H, Al-Dorzi HM, Sadat M, Arabi Y. Association between β-blocker use and mortality in critically ill patients: a nested cohort study. BMC Pharmacol Toxicol. 2018 May 16;19(1):22. doi: 10.1186/s40360-018-0213-6. PMID: 29769112; PMCID: PMC5956834.

Journal of Trauma Nursing

Opioid requirements in mechanically ventilated trauma patients receiving dexmedetomidine versus propofolOhoud A Aljuhani, Courtney B McKinney, Brian L Erstad

Critical Care

Evaluation of zinc sulfate as an adjunctive therapy in COVID-19 critically ill patients: A Two Center Propensity-Score Matched Study
Khalid Al Sulaiman, Khalid Al Sulaiman BCCCP, BCNSP,, Ohoud Aljuhani Pharm.D, BCCCP, Abdulrahman I Al Sh ya Pharm.D, Abdullah Kharbosh Pharm.D, Raed Kensara Pharm.D, Alhomaidi Al Guwairy Pharm.D, Aisha Alharbi Pharm.D, Rahmah Algarni Pharm.D, Shmeylan Al Harbi Pharm.D, , Ramesh Vishwakarma PhD  statistics, Ghazwa B. Korayem, Pharm.D, BCPS 

Journal of Intensive Care Medicine

The Role of Inhaled Corticosteroids (ICS) in Critically Ill Patients With COVID-19: A Multicenter, Cohort Study
Khalid Al Sulaiman, Ohoud Aljuhani,, Kholoud Al Aamer, Omar Al Shaya, Abdulrahman Al Shaya, Alawi S. Alsaeedi, Alaa Alhubaishi, Ali F. Altebainawi, Alaa Al Harthi, Shorouq Albelwi, Rahaf Almutairi, Norah Alsubaie, Alanoud Alsallum, Ghazwa B. Korayem, Amjaad Alfahed, Raed Kensara, Elaf F. Altebainawi, Raghdah S. Alenezi, Thamer Alsulaiman, Huda Al Enazi, Ramesh Vishwakarma, Tarek Al Dabbagh, Umar Bakhsh, Ghassan Al Ghamdi

BMC infectious diseases

Tocilizumab Association with Emerging Multi-drug Resistance Organisms and Mortality in critically ill patients with Coronavirus disease 2019 (COVID-19): A Multicenter, Retrospective Cohort StudyOhoud Aljuhani, Khalid Al Sulaiman, Adel Alshabasy, Khalid Eljaaly, Abdulrahman I. Al Shaya, Hyatham Albossiry, Mohammed Abodeif, Bodoor Al Dosari, Amina Alkhalaf, Ghazwa Korayem, Muneera M. Aleissa, Hisham A. Badreldin,Shmeylan Al Harbi,Abdullah Alhammad, Ramesh Vishwakarma 

Clinical and Applied Thrombosis/Hemostasis

Appropriateness of Using Vitamin K for the Correction of INR Elevation Secondary to Hepatic Disease in Critically ill Patients: An Observational StudyKhalid Al Sulaiman, Mashael Al Mutairi , Omar Al Harbi , Alanoud Al Duraihim , Sara Aldosary , Haifa Al Khalil , Abdulrahman Al Shaya, Shmeylan Al Harbi, Nouf Alotaibi , Kholoud Al Aamer, Ramesh Vishwakarma, Mohammed Al Asiri , Ohoud Aljuhani , Abdulmalik Al Katheri and Abdulkareem M. Al Bekairy

BMC Infectious Disease

The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram‑positive infection: A retrospective cohort studyKhalid Al Sulaiman, Abdulrahman Alshaya, Ohoud Aljuhani, Amjad Alsaee , Nadiyah Alshehri, Ramesh Vishwakarma, Hamdan Alzahrani, Sara Althewaibi, Nawaf Alghamdi, Khalid Alhelal, Aisha Alharbi and Shmeylan Al Harbi

Journal of Pharmacy Practice

The role of ursodeoxycholic acid in critically ill patients with sepsis: A Retrospective StudyKhalid Al Sulaiman, Abdullah Kharbosh, Khalid Bin Salah, Thamer Alsulaiman, Norah Al Andas, Ohoud Aljuhani, Ramesh Vishwak rma

Journal of Cardiovascular Development and Disease (JCDD)

What the near Future Holds for Sacubitril/Valsartan: A Summary of Major Ongoing StudiesHisham A. Badreldin, Nasser Aldosari, Lama Alnashwan, Taif Almutairi, Nada Yousif, Khalid Al Sulaiman, Ohoud Aljuhani, Awatif Hafiz, Omar Alshaya

Saudi Pharmaceutical Journal (SPJ)

Comparison Between Standard Vs. High Dosing Venous Thromboembolism (VTE) Prophylaxis in COVID19 Critically Ill Patients: A Multicenter, Observational StudyOhoud Aljuhani, Khalid Al Sulaiman, Awattif Hafiz, Khalid Elja ly, Aisha Alharbi, Rahma Algarni, Sarah Al Homaid, Khawla Al Qahtani, Tareq Alsulaiman, Ramesh Vishwakarma, Ghassan Al Ghamdi, Mai Alalawi, Ghazwa B. Korayem

Journal of Blood Medicine

Apixaban use in patients with protein S deficiency in Saudi Arabia: A case series and Review of Literature  Khalid Al Sulaiman, Faisal Alsuwayyid, Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Almutairi, Fahad Alharthi, Laila Abu Esba, Ohoud Aljuhani, Hisham A. Badreldin 

Respirology Journal

Letter from Saudi ArabiaOhoud Aljuhani, Khalid Al Sulaiman

Saudi Journal of Clinical Pharmacy

Comparison of the Efficacy and Safety of Enoxaparin vs Unfractionated heparin for Venous Thromboembolism (VTE) Prophylaxis in Critically ill Medical PatientsKhalid Al Sulaiman, Asma Alshehri, Ramesh Vishwakarma, Umar Bakhsh, Abdullah Kharbosh, Amirah Mokali, Ohoud Aljuhani

Journal of Intensive Care Medicine

Evaluation of low-dose aspirin use among COVID-19 critically ill patients: A Multicenter Propensity Score Matched StudyAbdullah Al Harthi, Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Ra hdah S. Alenezi, Shmeylan Al Harbi, Jawaher Gramish, Raed Kensara, Awattif Hafidh, Huda Al Enazi, Ahad Alawad, Rand Alotaibi, Abdulaziz Alshehri, Omar Alhuthaili, Ramesh Vishwakarma, Khalid bin Saleh, Thamer Alsulaiman, Rahaf Ali Alqahtani, Saja Almazrou, Sajid Hussain

Infection and Drug Resistance 

Colistin Loading Dose in Septic Patients with Gram Negative InfectionsAbdulrahman I Alshaya, Khalid Bin Saleh, Mohammed Aldhaeefi, Hisham A Baderldin, Farris O Alamody, Qusai A Alhamdan, Mohammed A Almusallam, Omar Alshaya, Khalid Al Sulaiman, Shaima Alshareef, Shuroug A Alowais, Shmeylan A Al Harbi, Ghassan Alghamdi

Thrombosis Journal

Evaluation of Apixaban safety and effectiveness in morbidly obese patients with atrial fibrillation: a retrospective cohort studyKhalid Al Sulaiman, Hisham A Badreldin, Ghazwa B Korayem, Abeer A Alenazi, Faisal Alsuwayyid , Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Almutairi, Fahad Alharthi, Ramesh Vishwakarma , Omar Al Shaya, Abdulrahman Al Amri, Saqiba Tayyab , Abdulkareem M Al Bekairy, Ohoud Aljuhani

Journal of Investigative Medicine High Impact Case Reports

Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and Review of LiteratureKhalid Al Sulaiman, Awatif Hafiz, Hisham A. Badreldin, Ghazwa B. Korayem, Faisal Alsuwayyid, Abdulrahman Alrashidi, Mohammed Alhijris, Faisal Almutairi, Fahad Alharthi, Saad Alghamdi, Ahmed Abu Alreesh, Ohoud Aljuhani

Scientific Clinical and Applied Thrombosis/Hemostasis

Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort StudyShmeylan Al Harbi, Raed Kensara, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Abdullah Al Harthi, Ramesh Vi hwakarma, Alaa M. Alenazi, Abdulmajed Almutairi, Omar Alshaya , Sultan Alraddadi, Tareq Al Sulaiman, Latifah Aldakkan, Reem Mahboob, Kholoud Alaamer, Abdulrahman Alissa, Awatif Hafiz, Nada Aldhayyan, Sara Althewaibi, Farhan Alenezi, Nadeen Y. Alkhotani, Sara A. Alghamdi, Abeer A. Alenazi, and Khalid Al Sulaiman

Scientific Report

Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study Cohort StudyKhalid Al Sulaiman, Ghazwa B. Korayem, Khalid Eljaaly, Ali F. Altebainawi, Omar Al Harbi, Hisham A. Badreldin, Abdullah Al Harthi, Ghada Al Yousif, Ramesh Vishwakarma, Shorouq Albelwi, Rahaf Almutairi, Maha Almousa, Razan Alghamdi, Alaa Alhubaishi, Abdulrahman Alissa, Aisha Alharbi, Rahmah Algarni, Sarah Al Homaid, Khawla Al Qahtani, Nada Akhani, Abdulaleam Al Atassi, Ghassan Al Ghamdi & Ohoud Aljuhani

International Journal of Infectious Diseases

The safety and effectiveness of tocilizumab in older adult critically ill patients with COVID-19: a multicenter, cohort study with COVID-19: a multicenter, cohort study Cohort StudyGhazwa B. Korayem, Ohoud Aljuhani, Ali F. Altebainawi, Abdulrahman I. Al Shaya , Lina I. Alnajjar, Abdulrahman Alissa , Mohammed Aldhaeefi, Raed Kensara, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Omar Alhuthaili, Ramesh Vishwakarma, Namareq Aldardeer, Khalid Eljaaly, Aisha Alharbi, Shmeylan Al Harbi, Abdulmalik Al Katheri, Abdulkareem M. Al Bekairy, Ahmed Aljedai, Khalid Al Sulaiman

Saudi Journal of Clinical Pharmacy

Critical Care Pharmacy Program Accreditation Standards Framework and Core Competencies in Saudi Arabia: An Opinion Paper by the SSCP Critical Care and Emergency Medicine Pharmacy Specialty NetworkAbdulrahman I. Alshaya, Ohoud Aljuhani, Sultan M. Alghadeer, Nadia Ismail, Nada Alkhani, Shmeylan Alharbi, Ahmed O. Alenazi, Rayd Almehizia, Khalid Al Sulaiman, Ahmed Aljabri, Hussain Buksh, Abdullah M. Alhammad

International Journal of Environmental Research and Public Health

Assessing the Perception of Pharmacy Students on Launching a Doctor of Pharmacy/Master of Public Health Dual Degree Program in Saudi Arabia: A Multi-Institutional Cross-Sectional StudyHisham A. Badreldin, Khalid Bin Saleh, Aisha F. Badr, Abdullah Alhifany, Shuroug A. Alowais, Sumaya N. Almohareb, Nada Alsuhebany, Abdulmajeed Alshehri, Mohammed Alzahrani, Anas Aldwsari, Ohoud Aljuhani , Ghazwa B. Korayem, Khalid Al Sulaiman , Allulu Alturki, Hayfa Alhaidal and Yazeed Ghawaa

Journal of International Medical Research

The correlation between non-O blood group type and recurrent catheter-associated urinary tract infections in critically ill patients: A retrospective studyKhalid Al Sulaiman , Nouf Al Qahtani, Mashael Al Muqrin, Maram Al Dossari, Ali Al Wabel, Tareq Al Sulaiman, Ramesh Vishwakarma, Abdulaziz Alolayan, Fatimah Abudayah, Ghazwa B. Korayem and Ohoud Aljuhani

IDCases

A case report on the association between QTc prolongation and remdesivir therapy in a critically ill patientShmeylan Al Harbi , Mashael AlFaifi,  Hasan M Al-Dorzi, Ohoud Aljuhani, Abeer A Alenazi,  Mai Alalawi, Khalid Al Sulaiman 

Frontiers in Neuroscience

Vitamin D serum level predicts stroke clinical severity, functional independence, and disability—A retrospective cohort studyAbdullah R. Alharbi, Amer S. Alali3, Yahya Samman, Nouf A. Alghamdi, Omar Albaradie, Maan Almaghrabi, Seraj Makkawi, Saeed Alghamdi, Mohammad S. Alzahrani, Mohammed Alsalmi, Vardan T. Karamyan, Khalid Al Sulaiman, Ohoud Aljuhani and Faisal F. Alamri

Frontiers in Public Health

The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort studyKhalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hadeel Alkofide and Hasan M. Al-Dorzi

Journal of Applied Hematology

Does Carbapenem Resistant Enterobacteriaceae Infection Drive Venous Thromboembolism in Patients Admitted to Intensive Care Units Receiving Prophylactic Anticoagulants?Fahad Aleidan, Sara Albilal, Maha Alammari, Khalid Al Sulaiman, Mohammed Alassiri, Abdel Galil Abdel Gadir

Journal of Infection and Public Health

Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective studyHakeam A. Hakeama, Ghadi Askarb,, Khalid Al Sulaimanc, Reem Mansoure, Maha M. Al Qahtanid, Dana Abbarab, Nada Aldhayyand, Nariman Dyabd, Liyan Afanehb, Muna Islamif, Zainab Al Duhailiba

Saudi Critical Care Journal

Evaluation of standard dosing for selected broad‑spectrum Hydrophilic antibiotics in critically ill patients with Augmented renal clearance: An Observational StudyMajed Almutairi, Khalid Al Sulaiman, Sultan Alenazi, Ramesh Vishwakarma, Ohoud Aljuhani

Critical Care Journal

Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort studyKhalid Al Sulaiman, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Alissa, Abdullah Alharthi, Raed Kensara, Amjaad Alfahed, Ramesh Vishwakarma,  Hussain Al Haji, Naif Almohaimid, Omar Al Zumai, Fahad Alrubayan, Abdulmajid Asiri, Nasser Alkahtani, Abdulaziz Alolayan, Samiah Alsohimi, Nawal Melibari, Alaa Almagthali, Seba Aljahdali, Abeer A. Alenazi, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Omar Al Faris, Joud Alqahtani, Jalal Al Qahtani, Khalid A. Alshammari, Khalil I. Alshammari, and Ohoud Aljuhani

Saudi Critical Care Journal

0.9% Sodium Chloride Versus Dextrose 5% in Water Safety as Medication’s Diluents in Critically Ill Patients: Meta‑Analysis of Observational StudiesSamiah Alsohimi, Alaa Almagthali, Khalid Eljaaly, Ghazwa B. Korayem, Khalid Al Sulaiman, Ohoud Aljuhani

Journal Of Pakistan Medical Association

Pain in sickle cell diseases; physicians’ knowledge, attitude, and barriers: A cross sectional studyOhoud Aljuhani

Saudi Pharmaceutical Journal (SPJ)

The potential role of adjunctive ascorbic acid in the prevention of colistin-induced nephrotoxicity in critically ill patients: A retrospective studyKhalid Al Sulaiman, Ohoud Aljuhani, Abdullah M. Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Alshareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Ramesh Vishwakarma, Numan Alabdan, Yousef Alrajhi, Abdulmalik Al Katheri, Abeer A. Alenazi, Mai Alalawi, Ghassan Al Ghamdi

American Journal of Case Report

Therapeutic Plasma Exchange and Supratherapeutic Levels of Unfractionated Heparin in the Management of Critically Ill Patient with Myasthenia Gravis: A Case ReportShaden D. Alshehri, Khalid Al Sulaiman, Ohoud Aljuhani, Shmeylan A. Al Harbi, Mai Alalawi, Abeer A. Alenazi, Raed Kensara, Omar A. Alshaya

Brazilian Journal of Pharmaceutical Sciences

The Role of Critical Care Pharmacists Beyond Intensive Care Units: A Narrative Review on Medication Management for ICU SurvivorsOhoud Aljuhani

Thrombosis Journal

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID‑19: a multicenter propensity‑score matched studyKhalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Awatif Hafiz, Mai Alalawi, Hisham A. Badreldin, Ali F. Altebainawi, Ramesh Vishwakarma, Abdulrahman Alissa, Albandari Alghamdi, Abeer A. Alenazi, Huda Al Enazi, Shahad Alanazi, Abdullah Alhammad1, Jahad Alghamdi, Mashael AlFaifi, Faisal A. Al Sehli, Maram A. Aldossari, Alaa A. Alhubaishi, Anfal Y. Al‑Ali and Hasan M. Al‑Dorzi

Saudi Journal of Clinical Pharmacy

Clinical Pharmacist Interventions in Intensive Care Units during Hajj: A Multicenter Retrospective StudyKhalid Al Sulaiman, Ohoud Aljuhani, Mahasen Al Harbi, Abrar K Thabit, Abdullah F Alharthi, Namareq Aldardeer, Ahmed O Alenazi, Badr Alghamdi, Dema Alissa, Hajer Almudaiheem, Wafa Alluwaymi, Sahar Almushaikah, Rana Almustaneer, Mohammed Alshennawi, Ahmed Al-jedai

Clinical Pharmacology: Advances and Applications

Chemical versus Mechanical and Chemical Venous Thromboembolism Prophylaxis in Neurocritically Ill Patients: A Cohort StudyAbdulrahman I Alshaya, Hayaa Alyahya, Reema Alzoman, Rawa Faden, Omar A Alshaya, Khalid Al Sulaiman, Faisal Alanazi, Sara Aldekhyl 

Journal of Intensive Care Medicine

Evaluation of Early Tocilizumab Effect on Multiorgan Dysfunction in Critically Ill Patients With COVID-19: A Propensity Score-Matched StudyOhoud Aljuhani, PharmD, Ghazwa B. Korayem, PharmD, Ali F. Altebainawi, PharmD, Abdullah Al Harthi, PharmD, Hisham A. Badreldin, PharmD, Muath A. Alsalloum, PharmD, Khalid Eljaaly, Pharm, Aisha Alharbi, PharmD, Rowina Aljehani, PharmD, Ramesh Vishwakarma, PhD, Abeer A. Alenazi, PharmD, Mai Alalawi, PharmD, Abdulrahman Alissa, PharmD, Kholoud Al Aamer, PharmD, Huda Al Enazi, PharmD, Mohammed Almusallam, PharmD, Abdulaziz Alshehri, PharmD, Rawan Bukhari, PharmD, Ghaday Alasmari, PharmD, Maha M. AlQahtani, PharmD, Sultanah Al Shammari, PharmD, Hatim O. Alsulaymi, PharmD, and Khalid Al Sulaiman, BCCCP, BCNSP, MBA, FCCM

The Pharmacogenomics Journal

Targeted next-generation sequencing of genes involved in Warfarin Pharmacodynamics and pharmacokinetics pathways using the Saudi Warfarin Pharmacogenetic study (SWAP)

Maha Al Ammari, Bader Almuzzaini, Khalid Al Sulaiman, Mohammed AlBalwi, Khizra Sultana, Ibrahim B. Alabdulkareem, Nada S. Almakhlafi1, Anoud Al Humoud, Mohammed Waheeby, Munee Balla, Asma Al Shehri, Adel Alharf and Jahad Alghamdi


BMC Infectious Disease

The clinical outcomes of COVID‑19 critically ill patients co‑infected with other respiratory viruses: a multicenter, cohort study

Khalid Al Sulaiman*, Ohoud Aljuhani, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Ahlam H. Alharbi, Albandari Alghamdi, Alaa Alhubaishi, Ali F. Altebainawi, Mohammad Bosaeed, Rand Alotaibi, Ahad Alawad, Nirvana Alnajjar, Khalid Bin Saleh, Walaa A. Sait, Samiah Alsohimi, Meshari M. Alanizy, Sarah A. Almuqbil, Ibrahim Al Sulaihim, Ramesh Vishwakarma, Mai Alalawi, Fatimah Alhassan and Suliman Alghnam


Saudi Pharmaceutical Journal (SPJ)

The effect of oseltamivir use in critically ill patients with COVID-19: A multicenter propensity score-matched study

Ohoud Aljuhani, Ghazwa B Korayem , Ali F Altebainaw, Meshal S Alotaibi, Noura A Alrakban, Ragia H Ghoneim , Ramesh Vishwakarma , Abdulrahman I Al Shaya , Shmeylan Al Harbi , Jawaher Gramish , Dahlia M Almutairi , Ghada Alqannam , Faisal F Alamri , Abdullah F Alharthi , Mashael Alfaifi, Abdullah Al Amer , Abeer A Alenazi , Norah Bin Aydan , Mai Alalawi , Khalid Al Sulaiman 


Clinical and Applied Thrombosis/Hemostasis

Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19

Raed Kensara , Ohoud Aljuhani , Ghazwa B Korayem , Hadeel Alkofide, Sumaya N Almohareb , Yousef S Alosaimi, Ali F Altebainawi, Khalid Bin Saleh , Norah Al Andas , Shmeylan Al Harbi, Abdullah F Al Harthi , Uhood Ashkan , Rema Alghamdi , Hisham A Badreldin, Awatif Hafiz , Mashael AlFaifi , Rahaf A Alqahtani , Ramesh Vishwakarma, Abeer A Alenazi , Mai Alalawi, Reem Mahboob, Renad A Alfouzan, Layan B Al Tuhayni  , Nouf Al Qahtani, Khalid Al Sulaiman 


Frontiers in Medicine

Clinical Pharmacy Faculty Provision of Direct Patient Care, Challenges, and Opportunities

Ghazwa B. Korayem, Lama Ali Alqahtani, Sultanah Hisham Alsulaiman, Abdullah M. Alhammad, Hisham A. Badreldin, Nora Alkhudair, Khalid Al Sulaiman and Ohoud Aljuhani


Saudi Pharmaceutical Journal (SPJ)

Safety and tolerability of Empagliflozin use during the holy month of Ramadan by fasting patients with type 2 diabetes: A prospective cohort study

Mayada M. Samkari, Neda’a S. Bokhari, Raghad Alhajaji, Malaz E. Ahmed, Ahmad Al Raddad, Alaa K. Bahget, Sarah F. Saleh, Faisal Aljehani, Saud H. Alzahrani, Sarah S. Alsifyani, May M. Samkari, Aisha F. Badr, Mai Alalawi, Khalid Al Sulaiman


Clinical and Applied Thrombosis/Hemostasis

Doxycycline’s Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study

Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Lina I. Alnajjar, Ali F. Altebainawi, Mashael AlFaifi, Ramesh Vishwakarma, Abeer A. Alenazi, Mai Alalawi, Abdulrahman Alissa, Yazed S. Alsowaida, Samiah Alsohimi, Alaa Almagthali, Saeed M. Alay, Noora Altaher, Mohammed G. Alamri, Dalal Alangari, Amer Alzahrani, Habeeb Ibrahim Abdul Razack, Jwael Alhamoud, Abdulrahman Alshaya, Jawaher Gramish, Kholoud Al Aamer, Alawi S. Alsaeedi, and Ghassan Alghamdi


Journal of Infection and Public Health

Clinical pharmacy services in acute care setting during mass gatherings (Hajj): Insights from a task force

Ohoud Aljuhani, Khalid Al Sulaiman , Abdulkareem M Al Bekairy,  Khalil Almajed, Mahasen Al Harbi, Abrar K Thabit, Abdullah F Alharthi, Namareq Aldardeer, Hisham A Badreldin, Abdullah M Alhammad, Ahmed O Alenazi, Badr Alghamdi, Samiah Alsohimi, Mohammed Alshennawi, Abdulrahman I Alshaya, Mohammed Alrashed, Omar A Al Shaya, Ahmed Al-Jedai


Annals of Pharmacotherapy

The Impact of Midodrine Tapering Versus Nontapering Regimens on the Clinical Outcomes of Critically Ill Patients: A Retrospective Cohort Study

Jawaher Gramish , Ahmed Hattan, Ohoud Aljuhani, P J Parameaswari, Shaden Alshehri, Ghazwa B Korayem, Hadeel Alkofide , Mai Alalawi, Ramesh Vishwakarma, Yazed Saleh Alsowaida, Rahaf Alqahtani,  Luluh Binorayir, Mohammed Abutaleb, Alanoud Alotaibi, Majidah Aljohani , Sarah Aljohani, Sana Samreen, Suad Jawhari, Raghad Alanazi, Khalid A Al Sulaiman


Journal of Infection and Public Health

When antivirals backfire: An evaluation of favipiravir's clinical outcomes in critically ill patients with COVID-19: A multicenter cohort study

Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B Korayem, Ali F Altebainawi, Mashael AlFaif, Majed Nahari, Alaa Almagthali, Abrar K Thabit, Raghad Alhajaji , Reham Alharbi, Khawla Kahtani, Abeer A Alenazi , Aisha Alharbi, Munirah M Alghwainm , Sara M Alotaibi , Yazeed S Alghamdi, Samar Alotaibi, Shaden H Alonazi , Jumanah M Almutairi , Ramesh Vishwakarma 


Clinical and Applied Thrombosis/Hemostasis

Thromboprophylaxis in Hospitalized Non-Critically III Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis

Awatif Hafiz, Hadeel Alkofide, Khalid Al Sulaiman, Hala Joharji, Sarah Aljohani, Khadijah A Sarkhi, Reem Alharbi, Ghazwa B Korayem, Mashael AlFaifi, Samiah Alsohimi, Ohoud Aljuhani

Journal of Critical Care

International pharmacy survey of peripheral vasopressor infusions in critical care (INFUSE)

Arwa Abu Sardaneh, Jonathan Penm, Matthew Oliver, David Gattas, Andrew J. McLachlan, Christie James, Christina Cella, Ohoud Aljuhani, Nicole M. Acquisto, Asad E. Patanwala

Frontiers in Medicine

Survival implications vs. complications: Unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19-A multicenter cohort study

Khalid Al Sulaiman, Ghazwa B Korayem , Ohoud Aljuhani, Ali F Altebainawi, Mohammad S Shawaqfeh, Sumaiah J Alarfaj, Reham A Alharbi, Mawaddah M Ageeli , Abdulrahman Alissa, Ramesh Vishwakarma, Alnada Ibrahim, Abeer A Alenazi, Suliman Alghnam, Nadiyah Alshehri, Maqbulah M Alshammari, Alaa Alhubaishi, Mohammed Aldhaeefi , Faisal F Alamri , Yadullah Syed , Raymond Khan , Mai Alalawi , Khalaf A Alanazi, Faisal S Alresayes  , Khalid J Albarqi , Ghassan Al Ghamdi

BMC Pulmonary Medicine

Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study

Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B Korayem, Ali F. Altebainawi, Reham Alharbi, Maha Assadoon, Ramesh Vishwakarma, Nadia H Ismail, Asma A Alshehri, Faisal E Al Mutairi, Mashael AlFaifi, Abdullah F Alharthi, Abeer A Alenazi, Mai Alalawi , Omar Al Zumai, Hussain Al Haji, Sarah T Al Dughaish, Abdulrahman S Alawaji , Haifa A Alhaidal, Ghassan Al Ghamdi

Journal of Infection and Public Health

Assessing the influence of COVID-19 on influenza prevalence: A multicenter time series study

Khalid Bin Saleh, Hisham A. Badreldin, Tariq Alqahtani, Nada Alsuhebany, Shuroug A. Alowais, Khalid Al Sulaiman, Mohammed Alrashed, Yara Alsaeed, Abdulrahman Alyousef, Rema Aldugiem, Ohoud Aljuhani, Naif Alharbi, Suliman Alghnam, Ahmed Almotiri, Hosam M. Zowawi, Nadiyah Alshehri, Sameera Al Johani, Mohammad Bosaeed

Renal Failure

The use of Tocilizumab in COVID-19 critically ill patients with renal impairment: a multicenter, cohort study

Ohoud Aljuhani, Khalid Al Sulaiman, Ghazwa B Korayem, Aisha Alharbi, Ali F. Altebainawi, Shatha A. Aldkheel, Sarah G. Alotaibi, Ramesh Vishwakarma, Hanan Alshareef, Samiah Alsohimi, Mashael AlFaifi, Abdulrahman Al Shaya, Haifa A. Alhaidal, Raghad M. Alsubaie, Hessah Alrashidi, Khalid J. Albarqi, Dalal T. Alangari, Reem M. Alanazi, Noora M. Altaher & Hasan M. Al-Dorzi

Science Progress

Clonidine safety and effectiveness in the management of suspected paroxysmal sympathetic hyperactivity post-traumatic brain injury: A retrospective cohort study

Abdulrahman I Alshaya , Mohammed Aldhaeefi, Nada Alodhaiyan , Maha Alqahtani , Sarah Althewaibi , Wala Alshahrani , Khalid Al Sulaiman, Shmeylan A Al Harbi, Ramesh Vishwakarma , Tariq Aldabbagh

Clinical and Applied Thrombosis/Hemostasis

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study

Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Ramesh Vishwakarma, Mashael AlFaifi, Samiah Alsohimi, Aljoharah Alrayes, Sara Albishi, Reem Alqahtani, Mai Alalawi, Ibrahim Al Sulaihim, Thamer A. Alanazi, Rahaf A. Alqahtani, Alaa Almagthali, Shahamah Jomah, Areej Alshlowi, Tahani R. Alshammari, Shahad S. Alzahrani, and Marwa I. Abdulqader

Medicine

Real-world analysis of integration of sacubitril/valsartan into clinical practice in Saudi Arabia  

Hisham A Badreldin , Ghazwa B Korayem, Basel A Alenazy , Mousa H Aljohani , Omar A Alshaya, Khalid Al Sulaiman , Lolwa Alabdelmuhsin , Huda Alenazi , Dahlia M Almutairi , Faisal Alanazi , Seba K Alobathani, Ghada M Alqannam, Ohoud Almadani, Ohoud Aljuhani, Awatif Hafiz , Ghalyah Aljowaie, Ehssan Basha , Tariq Alqahtani, Mosaad Alhussein

Clinical and Applied Thrombosis/Hemostasis

Evaluation of the Safety and Effectiveness of Topical Intrapleural Application of Tranexamic Acid in Thoracic Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Amer Alzahrani, Hadeel Alkofide , Hala Joharji, Ghazwa B Korayem , Sarah Aljohani , Hanan Alshareef , Mashael AlFaifi , Hassan Alalawi , Khalid Al Sulaiman

Saudi Journal of Clinical Pharmacy

Breaking Boundaries: Fostering a Culture of Collaborative Clinical Research

Khalid Al Sulaiman, Ohoud Aljuhani

European Journal of Trauma and Emergency Surgery

Comparison of the safety and efficacy for different regimens of pharmaco‑prophylaxis among severely burned patients: a randomized controlled trial

Khalid A. Al Sulaiman, Ghassan Al‑Ramahi, Ohoud Aljuhani, Khuloud Al‑Joudi, Abdulaziz K. Alhujayri, Feras Al‑Shomer, Johanna Silas, Tarek Al Dabbagh, Shmeylan Al Harbi, Salah AlDekhayel, Ahmed Eldali, Rahaf Alqahtani, Ramesh Vishwakarma, Hasan M. Al‑Dorzi

Medical books publication (s) 

Critical Care Cornerstone (Triple C) 

Dr. Khalid Al Sulaiman

Pharmacy Resident Shortcut

Dr. Khalid Al Sulaiman